Back to search

Cornell University

Mass spectrometry based proteomics and its applications in understanding disease progression and designing therapeutic strategies.

Abstract

dc:description.abstract

Quantitative proteomics offers transformative insights into molecular mechanisms underlying complex diseases; however, the inherent noise and variability in proteomic data pose significant challenges for accurate signal detection. This led to the development of the Maximal Aggregation of Good protein signal from Mass spectrometric data (MAGMa) tool, which leverages rigorous statistical testing to achieve a balance between sensitivity and specificity, effectively filtering out noise and enabling robust identification of subtle, true biological signals. MAGMa’s utility was validated on benchmarking datasets, where it consistently outperformed existing methods in identifying accurate interaction signals. MAGMa was applied to disease models with high therapeutic relevance, including SARS-CoV-2 and onco-fusion-driven cancers. In SARS-CoV-2 studies, MAGMa revealed a detailed host-pathogen interactome by identifying novel viral-host protein interactions. This approach led to the discovery of potential antiviral targets, with the drug carvedilol demonstrating promising antiviral effects in follow-up studies. In cancer models, MAGMa enabled us to dissect the altered protein interaction networks driven by oncogenic fusion proteins, identifying critical perturbations in the SWI/SNF chromatin remodeling complex in sarcoma. These findings shed light on the molecular underpinnings of fusion-mediated oncogenesis and open avenues for targeted cancer therapies. This corpus of work explores how network dynamics inform disease progression and the potential for computational tools to refine protein biomarkers as close phenotypic readouts. Results presented herein demonstrate how rigorous statistical methods can enhance the precision of proteomic analyses, making it possible to unravel complex biological interactions and prioritize drug targets. MAGMa provides researchers with a powerful tool to deepen insights into disease mechanisms and accelerate therapeutic discovery across a range of pathologies.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Computational Biology
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Computational Biology
Grantor
Cornell University
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gupta, Shagun
Chair dc:contributor.chair
  • Yu, Haiyuan
Committee members dc:contributor.committeemember
  • Booth, James
  • Mezey, Jason
  • Smolka, Marcus

Subjects

dc:subject × 6

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
16921875
Dc Identifier Other
ProQuest Submission ID: 14728
ProQuest Publication ID: 31639469

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Gupta, Shagun. Mass spectrometry based proteomics and its applications in understanding disease progression and designing therapeutic strategies.. Doctor of Philosophy thesis, Cornell University, 2024. https://hdl.handle.net/1813/117134